detsang Profile Banner
Derek Tsang Profile
Derek Tsang

@detsang

Followers
1K
Following
15K
Media
19
Statuses
127

Radiation Oncologist #RadOnc @RadMedPM @pmcancercentre @SickKids | Associate Professor @UofTDRO | he/him | tweets own opinion

Toronto, Ontario
Joined June 2009
Don't wanna be here? Send us removal request.
@WEMOcares
WEMOCares
2 months
@MHouseman010170 We hear you, Matt! We want to assure you that we have full visibility of the widespread issues affecting the WeMo application. Our engineers are working on a fix to quickly get your system running smoothly again.
1
1
1
@WEMOcares
WEMOCares
2 months
@mormishmom We hear you, Kyla. We understand the inconvenience. We're currently experiencing problems with our Wemo application and have reported this to our engineers. Rest assured, we're urgently working with them on a fix.
0
1
0
@detsang
Derek Tsang
3 months
It was a pleasure to co-lead this workshop alongside Dr Parkes and Dr Qureshi! Thank you for the invitation to speak. #radonc
@bmq_pk
Bilal Qureshi
3 months
Great engagement & interactive discussion with Drs Jeannette Parkes & Derek Tsang. Thank for being there and transfer of knowledge!
0
1
7
@intpros1
Paediatric Radiation Oncology Society (PROS)
3 months
Did you know Canada is the only G7 country without proton therapy? 🧑‍⚕️ Drs. @detsang & @_inhwakim reviewed a consult service that provides sample proton plans, showing lower brain & lung dose vs photons. It’s helped Canadians access U.S. treatment. 🔗 https://t.co/TMYgIUy3On
0
3
4
@detsang
Derek Tsang
1 year
@detsang.bsky.social
0
2
1
@PDBrownOnc
PDBrown
1 year
🚨 Randomized Trial OS benefit Low Grade Glioma w/TMZ 🚨
6
44
129
@ayabraincancer
Canadian AYA Neuro-Oncology Network
1 year
Amazing to see CANON clinician-researchers @detsang and @mjlimfat in Houston for #SNO2024!
@NeuroOnc
SNO
1 year
The #SNO2024 morning sessions begin: The Joint Debate on Clinical Controversies (SNO/EANO Young Investigators).
1
1
5
@Jan_M_Werner
Jan-Michael Werner
1 year
What a bright morning at #SNO2024. Start your day right with a lively debate of SNO and EANO young investigators. 7:15 at General Assembly B. @NeuroOnc @EANOassociation
1
9
42
@detsang
Derek Tsang
1 year
@detsang.bsky.social
0
2
1
@pmcancercentre
Princess Margaret Cancer Centre
1 year
A new @TheLancet study shows an immunotherapy drug can improve outcomes for cancer patients with advanced soft tissue sarcoma of the limb. Read more from #TeamUHN’s @DKirschMDPhD, Head of @RadMedPM & Radiation Oncology: https://t.co/dSEvG2sGc2
5
9
45
@safaviaa
Amir Safavi
1 year
Protons #IMPT ideal in some #headandneck scenarios per @imrtlee at @MSKCME #HNCSM mtg - NPC (?survival signal in ~studies) - ACC (unpublished ⬆️⬆️ LC & survival than hx) - Sinonasal - ReRT Some issues: - temp lobe + osteoRN rates/⏰ - flap comps? - biopsy post re-RT (DON’T)
0
3
5
@ebikesinternatl
ebikes-international
1 year
Massive Fight for Bikes Protest in Toronto to Save Bike Lanes & Lives, Ease Cogestion and Help Transport Goods #safecycling https://t.co/S0PxrLBXRa
9
32
149
@detsang
Derek Tsang
1 year
Proud to speak at the bike lane rally at Christie Pits park today. Read about it in the Toronto Star:
Tweet card summary image
thestar.com
The noisy but peaceful protest began with a rally at Christie Pits Park, with cyclists holding up signs saying “bike lanes save lives.”
2
2
7
@justinzw
Justin Z. Wang
1 year
Pleased to share our updated meningioma DNA methylation predictor with @ap_landry. Originally developed by @FarshadNassiri, @gelarehzadeh and prospectively validated through years of use @UHN @pmcancercentre tumour boards and more @detsang @afgao @Sty_md https://t.co/Ge1pR8qFhX
Tweet card summary image
academic.oup.com
AbstractBackground. We previously developed a DNA methylation–based risk predictor for meningioma, which has been used locally in a prospective fashion sin
0
9
26
@eunjtweet
Eunji Hwang
1 year
0
2
3
@detsang
Derek Tsang
1 year
Congratulations @eunjtweet on your important study! Glad to see our model was externally validated. #hearing #childhoodcancer #btsm
Tweet card summary image
ascopubs.org
PURPOSEHearing loss (HL) is a serious secondary effect of treatment for CNS and head-and-neck tumors in children. The goal of this study was to evaluate incidence and risk factors for HL in patients...
@eunjtweet
Eunji Hwang
1 year
We validated the novel @DanaKeilty @detsang hearing impairment model in paediatric patients treated with #protonbeamtherapy - joint first authorship with @simona_gaito in @RO_GreenJournal 🙌🏼 @edsmith_mcr @marianneaznar
1
2
12
@MichelSourour
Michel Sourour
1 year
RAIN clinic registered over 1,000 patients so far providing rapid access to neurosurgical care across the region! So happy to be part of the neurosurgery group @UHN @UofTNeuroSurge thank you @gelarehzadeh for developing the idea and making it possible!
0
1
20
@detsang
Derek Tsang
1 year
Pleased to report data on #pitNET tumours treated with #SRS demonstrating excellent results, no local failures, and ability to treat close to optic structures.
Tweet card summary image
link.springer.com
Journal of Neuro-Oncology - Pituitary neuroendocrine tumors (pitNETs) are benign tumors that may recur after surgical resection or persist following medical management. The objective of this study...
1
13
27
@detsang
Derek Tsang
1 year
It was a pleasure to join #proton education rounds at @nyproton - discussed our efforts to bring this remarkable radiation treatment to Canada 🇨🇦 - currently awaiting decision from government in Ontario 🤞
0
0
14